Insider Transactions in Q4 2023 at Processa Pharmaceuticals, Inc. (PCSA)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2023
|
Justin W Yorke |
SELL
Other acquisition or disposition
|
Indirect |
55,267
-10.63%
|
-
|
|
Oct 12
2023
|
Wendy Guy Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,771
+6.8%
|
$0
$0.34 P/Share
|
|
Oct 12
2023
|
Patrick Lin Chief Business - Strategy Off |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+1.05%
|
$0
$0.32 P/Share
|
|
Oct 12
2023
|
George K Ng Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+33.33%
|
$0
$0.25 P/Share
|
|
Oct 12
2023
|
David Young Pres. Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
155,277
+16.82%
|
$0
$0.29 P/Share
|
|
Oct 12
2023
|
Justin W Yorke |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+7.34%
|
$0
$0.3 P/Share
|
|
Oct 12
2023
|
James H Stanker Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+13.13%
|
$0
$0.33 P/Share
|
|
Oct 10
2023
|
Geraldine Pannu |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+7.24%
|
$0
$0.21 P/Share
|
|
Oct 10
2023
|
Patrick Lin Chief Business - Strategy Off |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+2.86%
|
$0
$0.21 P/Share
|
|
Oct 10
2023
|
David Young Pres. Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
142,000
+18.82%
|
$0
$0.24 P/Share
|
|
Oct 10
2023
|
George K Ng Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
$0
$0.25 P/Share
|
|
Oct 10
2023
|
Justin W Yorke |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+14.68%
|
$0
$0.21 P/Share
|
|
Oct 10
2023
|
James H Stanker Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+21.08%
|
$0
$0.24 P/Share
|